Incensole acetate
CAS No. 34701-53-6
Incensole acetate ( —— )
产品货号. M31442 CAS No. 34701-53-6
Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥789 | 有现货 |
|
| 10MG | ¥1254 | 有现货 |
|
| 25MG | ¥2465 | 有现货 |
|
| 50MG | ¥3860 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥603 | 有现货 |
|
生物学信息
-
产品名称Incensole acetate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.
-
产品描述Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.
-
体外实验Incensole acetate (100 μM; pre-treatment 4 hours) significantly ameliorates Aβ 25–35-induced cell death, a 48–52% decrease in cell viability at Aβ25–35 is restored to 85–89% upon pre-treatment with IA.Incensole acetate (5-100 μM) pretreatment reverses increase in the mRNA and protein level of Bax, caspase 8, cyto c and decrease in the mRNA and protein level of Bcl2 induced by Aβ 25–35 in hOBNSCs. Cell Viability Assay Cell Line:Human olfactory bulb neural stem cells Concentration:100 μM Incubation Time:Pre-treatment 4 hours Result:Increased hOBNSCs cell viability induced by Aβ 25-35.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number34701-53-6
-
分子量348.5
-
分子式C22H36O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (286.93 mM)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
RH01386
RH01386是一种小分子,可以预防内质网应激诱导的β细胞功能障碍和死亡,并抑制促凋亡基因表达,具有治疗2型糖尿病的潜力。 RH01386 可恢复内质网应激受损的葡萄糖刺激的胰岛素分泌反应。
-
DSP-0565
DSP-0565 (compound 17a) 是一种强效广谱的抗癫痫活性分子 (AED),具有γ-氨基丁酸的活性。DSP-0565 在不同动物模型中均表现出抗惊厥活性及安全性。
-
GSK2850163
GSK2850163 是一种新型肌醇需求酶 1 α (IRE1α) 抑制剂,可抑制 RNase 活性和 IRE1α 激酶活性(IC50:200 和 20 nM)。
021-51111890
购物车()
sales@molnova.cn

